These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2196193)

  • 1. [Effect of glipizide on glycemic control and peripheral insulin sensitivity in type 1 diabetics].
    Leblanc H; Thote A; Chatellier G; Passa P
    Diabete Metab; 1990; 16(2):93-7. PubMed ID: 2196193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.
    Simpson HC; Sturley R; Stirling CA; Reckless JP
    Diabet Med; 1990 Feb; 7(2):143-7. PubMed ID: 2137755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Absence of effect of enalapril on the glycemic control and peripheral sensitivity to insulin in 10 diabetic patients treated with subcutaneous continuous infusion of insulin].
    Leblanc H; Thote A; Billault B; Porquet D; Fisch A; Passa P
    Presse Med; 1988 Dec; 17(43):2277-80. PubMed ID: 2850552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin and sulphonylurea in the therapy of type 2 diabetes.
    Sotaniemi EA; Vierimaa E; Huupponen R; Karvonen I; Vuoti MJ; Rytömaa K
    Diabetes Res Clin Pract; 1990 Mar; 8(3):243-51. PubMed ID: 2111239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion from low-dose insulin therapy to glipizide in patients with non-insulin-dependent diabetes mellitus.
    Rosenstock J; Meisel A; Raskin P
    Am J Med; 1987 Sep; 83(3A):10-5. PubMed ID: 3307402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glipizide does not affect absorption of glucose and xylose in diabetics without residual beta-cell function.
    Lins PE; Kollind M; Adamson U
    Acta Med Scand; 1986; 219(2):189-93. PubMed ID: 3515865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of glucose and lactate after intravenous glipizide administration in some insulin-dependent diabetics. Therapeutic effects of an associated glipizide-insulin treatment.
    Giampietro O; Navalesi R; Buzzigoli G; Boni C
    Curr Med Res Opin; 1979; 6(5):325-30. PubMed ID: 396109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined use of insulin and sulfonylurea therapy in patients with non-insulin dependent diabetes mellitus.
    Reaven GM; Fraze E; Chen NY; Hollenbeck C; Chen YD
    Horm Metab Res; 1989 Mar; 21(3):132-6. PubMed ID: 2663691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short-term insulin therapy upon therapeutic response to glipizide.
    Schwartz SL; Fischer JS; Kipnes MS; Boyle M
    Am J Med; 1987 Sep; 83(3A):22-30. PubMed ID: 3307403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of glipizide combined with intensive insulin treatment for the induction of remissions in new onset adult type I diabetes.
    Selam JL; Woertz L; Lozano J; Robinson M; Chan E; Charles MA
    Autoimmunity; 1993; 16(4):281-8. PubMed ID: 8025207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
    Simonson DC; Kourides IA; Feinglos M; Shamoon H; Fischette CT
    Diabetes Care; 1997 Apr; 20(4):597-606. PubMed ID: 9096986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic equivalence of once- and thrice-daily glipizide.
    Wåhlin-Boll E; Groop L; Karhumaa S; Groop PH; Tötterman KJ; Melander A
    Eur J Clin Pharmacol; 1986; 31(1):95-9. PubMed ID: 3536529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
    Groop L; Wåhlin-Boll E; Groop PH; Tötterman KJ; Melander A; Tolppanen EM; Fyhrqvist F
    Eur J Clin Pharmacol; 1985; 28(6):697-704. PubMed ID: 3933984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.
    Goldstein BJ; Pans M; Rubin CJ
    Clin Ther; 2003 Mar; 25(3):890-903. PubMed ID: 12852706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glibenclamide improves the response to insulin treatment in non-insulin-dependent diabetics with second failure to sulfonylurea therapy.
    Lins PE; Lundblad S; Persson-Trotzig E; Adamson U
    Acta Med Scand; 1988; 223(2):171-9. PubMed ID: 3126626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes.
    Bao YQ; Zhou J; Zhou M; Cheng YJ; Lu W; Pan XP; Tang JL; Lu HJ; Jia WP
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):564-8. PubMed ID: 20082624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations.
    Fineberg SE; Schneider SH
    Diabetologia; 1980 Jan; 18(1):49-54. PubMed ID: 6988265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of insulin-glipizide combination on skeletal muscle capillary basement membrane width in diabetic patients.
    Camerini-Davalos RA; Bloodworth JM; Velasco CA; Reddi AS
    Clin Ther; 1994; 16(6):952-61. PubMed ID: 7697692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment.
    Groop L; Groop PH; Stenman S; Saloranta C; Tötterman KJ; Fyhrquist F; Melander A
    Diabetes Care; 1987; 10(6):671-8. PubMed ID: 3123184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.